IBM wants to put the patent war in perspective. Big Blue said that it is poised to get the most U.S. patents of any tech company for the 24th year in a row.
In 2015, IBM received more than 7,355 patents, down slightly from 7,534 in 2014. A spokesperson for IBM said the company is on track to receive well over 7,000 patents in 2016. In 2016, IBM is also hitting another interesting milestone, with more than 1,000 patents for artificial intelligence and cognitive computing.
IBM has been at it for more than a century, and it is seeking patents in key strategic areas — such as AI and cognitive computing. In fact, one-third of IBM’s researchers are dedicated to cognitive computing.
IBM CEO Ginni Rometty said during the World of Watson conference in October that the company expects to reach more than 1 billion consumers via Watson by the end of 2017. (Watson is the supercomputer that beat the world’s best Jeopardy player in 2011.)
While other companies are talking about increasing their AI patent applications, IBM is already reaping the benefits from a pipeline of AI patent applications filed years ago. This pipeline is producing a wave of AI/cognitive patents in 2016, which will be the first year that IBM receives more than 1,000 AI and cognitive computing patents in a single year.
To put the 1,000 AI patent achievement in perspective, it far exceeds Facebook’s entire 2015 patent total and is almost as many patents as Amazon received overall during 2015.
IBM’s increased AI/cognitive patent output during 2016 also has enabled the company to already exceed over 7,000 U.S. patents granted, for the third consecutive year. As a result, IBM is well ahead of its patent output from 2015. No other organization has ever obtained 7,000 U.S. patents in a single year.
Patents are a critical component of IBM’s strategy and growth plan, enabling the company to create leading-edge products and services for clients, protect its freedom of action in the marketplace, and generate significant income from its intellectual property. Patents also are the seeds of AI technologies, some of which were planted years ago and which you see in practice today — such as the IBM Watson-BMW project or the newly introduced Watson for cyber security beta program launched last week (with 40 clients globally). Other examples of Watson’s contribution can be found in partnerships with Pfizer and other leading healthcare companies that are pursuing drug discovery.
IBM has researchers around the U.S., including in New York, Texas, California, North Carolina, Minnesota, Vermont, and in a number of countries, including India, Germany, Israel, and others. These inventors are responsible for the more than 88,000 patents IBM has received during the past 20 years.